Mariafrancesca
Maternal oral microbiota plays a key role in influencing infant gut health and disease risk.
Patrick Veiga, Gut Microbiome & Nutrition Research Director at INRAE (France), discusses one of the major challenges in probiotic research: the variability of clinical trial outcomes.
Targeting the gut microbiota could help predict, prevent or reduce chemotherapy-related toxicity.
Certain bile acids produced by gut microbes can interact with specific receptors in the body, influencing immune cells to fight tumors.
